Q6GRK0 (Q6GRK0_HUMAN) Homo sapiens (Human)

Cytochrome P450 3A UniProtKBInterProInteractive Modelling

503 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: P08684

Available Structures

101 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Human CYP3A4 bound to a suicide substratehomo-4-mer26-496
100.0HEM;MWS;
Human CYP3A4 bound to a drug mibefradilhomo-4-mer26-496
100.0HEM;MWV;EDO;DMS;
Crystal structure of human CYP3A4 bound to an inhibitorhomo-4-mer27-497
100.0HEM;DJ1;
Crystal structure of human CYP3A4 bound to an inhibitorhomo-4-mer27-496
100.0HEM;D7Y;
Crystal structure of human CYP3A4 bound to an inhibitorhomo-4-mer28-496
100.0HEM;80K;
Human CYP3A4 bound to a drug substratehomo-4-mer28-496
100.0HEM;GOL;MWY;
Crystal structure of human CYP3A4 bound to an inhibitorhomo-4-mer29-496
100.0HEM;D7M;
Crystal structure of the midazolam-bound human CYP3A4homo-3-mer22-497
99.79HEM;08J;
Human CYP3A4 bound to PMSFhomo-2-mer26-497
100.0HEM;GOL;PMF; 14×EDO;DMS;
Human CYP3A4 bound to an inhibitor fluconazolehomo-2-mer26-497
99.78HEM;TPF;DMS;EDO;
Human CYP3A4 bound to a substratehomo-2-mer26-497
100.0HEM; 12×CFF;
Human CYP3A4 bound to an inhibitor metyraponehomo-2-mer26-497
100.0HEM;GOL;MYT;EDO;
Human CYP3A4 bound to a substratehomo-2-mer26-497
100.0HEM;UC7;GOL;
Crystal structure of the cysteine depleted CYP3A4 bound to glycerolhomo-2-mer26-496
98.7HEM; 24×GOL;
Human CYP3A4 bound to three caffeine moleculeshomo-2-mer26-496
100.0HEM;CFF;
Crystal structure of CYP3A4 bound to an inhibitorhomo-2-mer27-497
100.0HEM;X2Q;
Crystal structure of the cysteine depleted CYP3A4 bound to ritonavirhomo-2-mer26-496
98.69HEM;RIT;
CYP3A4 bound to an inhibitorhomo-2-mer27-497
100.0HEM;NJ0;
Crystal structure of CYP3A4 bound to an inhibitorhomo-2-mer26-496
100.0HEM;X2B;
Crystal structure of CYP3A4 bound to an inhibitorhomo-2-mer27-497
100.0HEM;X1I;
Crystal structure of CYP3A4 bound to an inhibitorhomo-2-mer26-496
100.0HEM;X0E;
Human CYP3A4 bound to an inhibitorhomo-2-mer26-496
99.56HEM;GOL;NXR;
Crystal structure of human CYP3A4 bound to an inhibitorhomo-2-mer27-497
100.0HEM;DEJ;
Human CYP3A4 bound to an inhibitorhomo-2-mer27-497
100.0HEM;QEA;
Crystal structure of the cysteine depleted CYP3A4 bound to bromoergocryptinehomo-2-mer28-497
98.7HEM;08Y;GOL;
Human CYP3A4 bound to an inhibitorhomo-2-mer27-496
100.0HEM;NJO;
Crystal structure of CYP3A4 bound to an inhibitorhomo-2-mer27-496
100.0HEM;X1C;
Crystal structure of CYP3A4 bound to an inhibitorhomo-2-mer27-496
100.0HEM;X2Q;
Crystal structure of human CYP3A4 bound to an inhibitorhomo-2-mer28-497
100.0HEM;D7J;
CYP3A4 bound to an inhibitorhomo-2-mer27-496
100.0HEM;NH0;
CYP3A4 bound to an inhibitorhomo-2-mer28-497
100.0HEM;NI6;
Crystal structure of human CYP3A4 with the caged inhibitorhomo-2-mer28-497
100.0HEM;GOL;X8S;
CYP3A4 bound to an inhibitorhomo-2-mer27-496
100.0HEM;QDJ;
Human CYP3A4 bound to an inhibitorhomo-2-mer27-496
99.56HEM;X7J;SO4;GOL;EDO;
Crystal structure of human CYP3A4 bound to metforminhomo-2-mer28-497
100.0MF8;HEM;
Human CYP3A4 bound to an inhibitorhomo-2-mer27-496
100.0HEM;QDV;
Human CYP3A4 bound to an inhibitorhomo-2-mer27-496
100.0HEM;QE4;
Human CYP3A4 bound to an inhibitorhomo-2-mer27-496
100.0HEM;T0K;
Crystal structure of CYP3A4 bound to an inhibitorhomo-2-mer28-496
100.0HEM;X1O;
Crystal structure of human CYP3A4 bound to an inhibitorhomo-2-mer28-496
100.0HEM;DEV;
Human CYP3A4 bound to an inhibitorhomo-2-mer28-496
100.0HEM;QEP;
Human CYP3A4 bound to an inhibitorhomo-2-mer28-496
99.56HEM;SO4;GOL;EDO;X74;
Crystal structure of human CYP3A4 with the caged inhibitorhomo-2-mer28-496
100.0HEM;X8P;
Human CYP3A4 bound to an inhibitorhomo-2-mer28-496
100.0HEM;GOL;X7P;
Crystal structure of human CYP3A4 bound to an inhibitorhomo-2-mer28-496
100.0HEM;Y83;
Crystal structure of human CYP3A4 with the caged inhibitorhomo-2-mer28-496
100.0HEM;O3L;
Human CYP3A4 bound to an inhibitorhomo-2-mer28-496
100.0HEM;X7M;
Crystal structure of human CYP3A4 bound to ritonavirhomo-2-mer28-496
100.0HEM;RIT;
Human CYP3A4 bound to an inhibitorhomo-2-mer29-497
100.0HEM;X6J;
Human CYP3A4 bound to an inhibitorhomo-2-mer28-496
100.0HEM;X71;
Crystal structure of human CYP3A4 bound to the testosterone dimerhomo-2-mer28-496
100.0HEM;YNV;
Crystal structure of human CYP3A4 bound to glycerolhomo-2-mer29-496
100.0HEM; 16×GOL; 24×EDO;
Crystal structure of CYP3A4 bound to an inhibitorhomo-2-mer29-496
100.0HEM;X4E;
Crystal structure of CYP3A4 bound to an inhibitorhomo-2-mer29-496
100.0HEM;WZN;
Crystal structure of CYP3A4 bound to an inhibitorhomo-2-mer29-496
100.0HEM;WZN;
Crystal structure of human CYP3A4 bound to an inhibitorhomo-2-mer29-496
100.0HEM;D81;
Human CYP3A4 bound to an inhibitorhomo-2-mer29-496
100.0HEM;A1APA;
Human CYP3A4 bound to an inhibitorhomo-2-mer29-496
100.0HEM;QES;
Human CYP3A4 bound to an inhibitorhomo-2-mer29-496
100.0HEM;QDY;
Human CYP3A4 bound to an inhibitorhomo-2-mer29-496
100.0HEM;SO4;X6S;
Human CYP3A4 bound to an inhibitorhomo-2-mer29-496
99.56HEM;PO4;NYF;
Human CYP3A4 bound to an inhibitorhomo-2-mer29-496
100.0HEM;X6V;
Human CYP3A4 bound to an inhibitorhomo-2-mer29-496
100.0HEM;SO4;GOL;EDO;X7D;
Crystal structure of human CYP3A4 with the caged inhibitorhomo-2-mer29-496
100.0HEM;O39;
Human CYP3A4 bound to an inhibitorhomo-2-mer29-496
100.0HEM;X5Y;
CYP3A4 bound to an inhibitorhomo-2-mer29-495
100.0HEM;
Crystal structure of human cytochrome P450 3A4monomer25-499
100.0HEM;
Crystal structure of human cytochrome P450 3A4monomer25-498
100.0STR;HEM;
Crystal structure of human cytochrome P450 3A4monomer25-498
100.0MYT;HEM;
Crystal Structure of Human Microsomal P450 3A4monomer28-499
100.0HEM;
Crystal structure of cytochrome P450 3A4 bound to progesteronemonomer26-497
100.0STR;HEM;
Crystal structure of cytochrome P450 3A4 bound to progesterone and citratemonomer26-497
100.0HEM;STR;CIT;
Cytochrome P450 3A4 bound to an inhibitormonomer27-497
100.0HEM;J9K;GOL;
Crystal structure of CYP3A4 in complex with an inhibitormonomer28-498
100.0HEM;2QH;
Human CYP3A4 bound to an inhibitormonomer27-496
100.0HEM;G0M;
Human CYP3A4 bound to an inhibitormonomer27-496
100.0HEM;G1J;
Human CYP3A4 bound to an inhibitormonomer27-496
100.0HEM;G0D;
Human CYP3A4 bound to an inhibitormonomer27-496
100.0HEM;FZV;
Crystal structure of human CYP3A4 coordinated to a water moleculemonomer28-497
100.0HEM;
Human CYP3A4 bound to an inhibitormonomer27-496
100.0HEM;GOL;G1D;
Crystal structure of CYP3A4 ligated to oxazole-substituted desoxyritonavirmonomer27-496
100.0HEM;Z8Z;
Human CYP3A4 bound to an inhibitormonomer27-496
100.0HEM;G0Y;
Human CYP3A4 bound to an inhibitormonomer27-496
100.0HEM;G0J;
Complex of human CYP3A4 with a desoxyritonavir analogmonomer27-496
100.0HEM;5AW;
Cytochrome P450 3A4 bound to imidazole and an inhibitormonomer29-497
100.0HEM;PK9;IMD;GOL;
Crystal structure of the cytochrome P4503A4-bromoergocryptine complexmonomer28-496
100.0HEM;08Y;
Cytochrome P450 3A4 bound to an inhibitormonomer28-496
100.0PK9;HEM;
Human CYP3A4 bound to an inhibitormonomer28-496
100.0HEM;FZV;GOL;GLN;
Complex of CYP3A4 with a desoxyritonavir analogmonomer29-497
100.0HEM;1RD;
Complex of CYP3A4 with a desoxyritonavir analogmonomer28-496
100.0HEM;6AW;
Human CYP3A4 bound to an inhibitormonomer28-496
100.0HEM;GOL;G0D;
Cytochrome P450 3A4 bound to an inhibitormonomer29-497
100.0HEM;PKT;
Crystal structure of human P450 3A4 in complex with ketoconazolemonomer30-498
100.0HEM;KLN;
Cytochrome P450 (CYP) 3A4 crystallized with clotrimazolemonomer28-496
100.0HEM;CL6;
Crystal structure of human cytochrome P4503A4 bound to an inhibitor ritonavirmonomer29-496
100.0DMS;HEM;RIT;
Crystal Structure of the complex between human cytochrome P450 3A4 and desthiazolylmethyloxycarbony…monomer29-496
100.0HEM;D0R;
Human CYP3A4 bound to an inhibitormonomer29-496
100.0HEM;GOL;G0V;
Complex of human CYP3A4 with a desoxyritonavir analogmonomer29-496
100.0HEM;7AW;
Crystal structure of human P450 3A4 in complex with erythromycinmonomer29-496
100.0HEM;ERY;
Complex of human CYP3A4 with a desoxyritonavir analogmonomer29-496
100.0HEM;8AW;
Crystal structure of CYP3A4 ligated to pyridine-substituted desoxyritonavirmonomer29-496
100.0HEM;Z9Z;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8so1.1.Bhomo-2-mer0.8726-496
HEM;CFF;100.00